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Introduction: Sulﬁte oxidase deﬁciency (SOD) is an autosomal recessive inherited disease usually presenting in the neonatal per-
iod with severe neurological symptoms including seizures, often refractory to anticonvulsant therapy, and a rapidly progressive
encephalopathy resembling neonatal hypoxic ischemia, with premature death. Most patients develop dislocated ocular lenses. Later
or milder presentations of SOD are being reported with increasing frequency. These presentations include neurological regression
with loss of previously acquired milestones or movement disorders. Case report: We report a four years old girl presenting with
intermittent ataxia and uncoordinated limb movements. A similar episode of ataxia had occurred previously, one year before, with
complete neurologic recovery and normal developmental milestones. Bilateral lens dislocation had been recently diagnosed. Cranial
MRI demonstrated bilateral globus pallidus enhancement. Low homocysteine was found in plasma and SulﬁtestR was positive. Fur-
ther investigations led to conﬁrmation of isolated sulﬁte oxidase deﬁciency with no enzyme activity detected on skin ﬁbroblasts cul-
ture. Discussion: This case illustrates the clinical variability of SOD and it is not only atypical but also seems to be the mildest form
described so far. The association of ectopia lentis with a movement disorder, even without psychomotor regression, should prompt
us to look for this diagnosis.
 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
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Sulﬁte oxidase is an enzyme in the terminal pathway
of sulfur aminoacid degradation. Isolated sulﬁte oxidase
deﬁciency (SOD) or deﬁciency of molybdenum, its
cofactor (MoCoD), are autosomal recessive inherited
diseases, usually with neonatal onset presenting with sei-
zures often refractory to anticonvulsant therapy, axial
hypotonia and limb hypertonicity and a rapidly progres-
sive encephalopathy leading to a state resembling that of0387-7604/$ - see front matter  2013 The Japanese Society of Child Neuro
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microcephaly, feeding diﬃculties and dislocated ocular
lenses. A few patients present with a milder late onset
form of the disease with dystonia and developmental
regression [1–3].
Biochemical features of the isolated form include
increased urinary excretion of sulﬁte, thiosulfate, taurine
and S-sulfocysteine and low plasma cystine and homo-
cysteine. Urinary excretion of xanthine and hypoxan-
thine is normal, and so is uric acid, unlike the
combined deﬁciency of sulﬁte and xanthine oxidase seen
in MoCoD (Fig. 1) [1–3].
The pathogenesis of neurotoxicity is not completely
understood but could comprise the accumulation of
glutamate, an excitotoxic neurotransmitter, due to thelogy. Published by Elsevier B.V. All rights reserved.
Fig. 1. Metabolic pathway of cysteine and xanthine metabolism.
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(GDH) and possibly alfa-ketoglutarate dehydrogenase
by sulﬁtes [4].
We report the mildest presentation form described so
far, with normal psychomotor development and recur-
rent episodes of ataxia.
2. Case report
This four-year-old girl was the second born, after a
full term pregnancy and a normal delivery. Her birth
weight was 3350 g, and the Apgar score was 9 and 10,
at one and ﬁve minutes, respectively. The neonatal
course was uneventful. The family history was unre-
markable and there was no consanguinity.
Growth, including head circumference, and psycho-
motor development were normal, except for a mild delay
of walking at 18 months. At 12 months of age, she pre-
sented with acute hypotonia, lasting a few hours. Neuro-
logical examination was normal and toxic screening was
negative. At three years, after a common ﬂu, she had a
24 h period of ataxia of which she recovered completely.
Basic metabolic and a second toxic screening were
negative.
At the age of four, three months after being diag-
nosed with bilateral lens subluxation, she was hospital-
ized because of persistent vomiting and moderate
dehydration. On the second day in hospital, she sud-
denly presented with axial and limb ataxia and erratic
eye and limb movements. Over the next few days,
residual generalized hypotonia, trunk and gait ataxia
were observed as well as two episodes of agitated
behaviour, worsening of gait ataxia and choreicmovements of lower limbs. She subsequently remained
well except for slight truncal ataxia that subsided grad-
ually. No further episodes were observed over the next
thirteen months.
Her head circumference is on the 50th percentile and
a formal psychomotor evaluation performed later on
showed just some diﬃculties on gross motor skills.
CT-scan was normal and lumbar puncture showed
normal pressure, no lymphocytes and no biochemical
abnormalities. EEG was normal. The blood cell count,
glucose, electrolytes, calcium, phosphate, pH, gases,
ammonia and lactate were within normal ranges but
plasma total homocysteine was extremely low
(0,6 mol/L, normal values >4 mol/L), and uric acid
was in the lower limit of reference values.
The diagnosis of SOD/MoCoD was suspected con-
sidering the context of dislocated lenses, a movement
disorder and a very low homocysteine.
Urinary SulﬁtestR was performed and was positive.
Plasma aminoacids revealed high levels of sulfocysteine
(14 mol/L, RV: 0–0,1) and very low cysteine (5 mol/L,
RV: 18–122). Urinary excretion of sulfocysteine was also
markedly increased (141 mol/mmol creat, RV: 0–0,1),
and taurine excretion was also high (280 mol/mmol creat,
RV: 17–230). Urinary xanthine and hypoxanthine levels
were normal. These ﬁndingswere consistentwith the diag-
nosis of isolated sulﬁte oxidase deﬁciency.
Sulﬁte oxidase activity in ﬁbroblast culture was unde-
tectable. Molecular analysis of SUOX gene in ﬁbro-
blasts revealed homozygosity for a previously
undescribed mutation on exon 2-c.182T > C-responsible
for the replacement of a leucine by a proline at codon 61
(p.Leu61Pro).
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globus pallidi, together with a thin corpus callosum and
an unusual dilatation of cerebral arteries (Fig. 2).
The patient was treated with a low protein diet and
thiamine supplementation.
3. Discussion
Since its ﬁrst description in 1967, several cases of
SOD have been reported, mostly with neonatal onset
showing tone abnormalities and refractory seizures
mimicking hypoxic-ischemic encephalopathy, with a
fatal course within few years [1–4]. Rare milder and later
presentations have been described [5–7], characterized
by a prominent movement disorder, usually with sei-
zures and psychomotor regression or delay.Fig. 2. (a) Axial PD-weighted image shows bilateral hyperintense signal of
callosum. (c) Axial PD-weighted image shows a mild and homogeneous ectaThe quantiﬁcation of plasma total homocysteine has
been previously proposed as a simple screening test for
this disorder (as the dipstick sulphite test may show false
negative results) because it was almost undetectable in
cases of isolated SOD and MoCoD [1,8–10]. Sulﬁtes
react readily with free thiol groups and conjugate with
cystine forming sulfocysteine. An analogous reaction
occurs with homocysteine, thus depleting plasma total
homocysteine (Fig. 1). It was the clue, in this case,
together with ectopia lentis, to search for this diagnosis.
The enzyme assay in cultured ﬁbroblasts surprisingly
showed undetectable activity but, as postulated before,
this assay may be probably not sensitive to detect a
residual activity in such mild forms [7].
Apart from the thin corpus callosum and abnormal
intensities of globus pallidi, no other gray or whiteglobus pallidi. (b) Sagittal T1-weighted image, showing a thin corpus
sia of both distal internal carotid arteries and middle cerebral arteries.
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such as cystic lesions, cortical atrophy or cerebellar
hypoplasia, were found [6,10,11].
There is previous evidence of a positive clinical and
biochemical eﬀect of a low protein diet from natural
foods supplemented with a formula without methionine,
cysteine and taurine in mild forms of isolated SOD [7].
We do not know if the improvement seen in our patient
was related to the low protein diet or to a spontaneous
recovery as in the previous episodes.
This case illustrates the phenotypic variability of
SOD and also seems to be the mildest clinical form
described so far.
The association of ectopia lentis with a movement dis-
order, even without psychomotor regression or epilepsy,
should therefore prompt us to look for this diagnosis.Acknowledgements
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